UNSPSC 51131831: Emicizumab

A hemophilia A treatment approved for people with hemophilia A with or without factor VIII inhibitors.

UNSPSC 51131831 Emicizumab is a Commodity code covering a monoclonal antibody pharmaceutical used in hemophilia treatment, yet the recent state and local contract opportunities posted under this code show little alignment with the pharmaceutical itself. Of the opportunities tagged to this code, only two contain material pharmaceutical or medical procurement scope: Dane County's RFP for comprehensive pharmaceutical services to a long-term care facility (Badger Prairie Health Care Center) and the City of Tucson Fire Department's RFP for basic and advanced life support (BLS and ALS) pharmaceuticals, supplies, and vending-machine platforms. The remaining tagged opportunities—a Palm Bay aquatic center operational model solicitation, a District of Columbia pharmacy benefits network RFQ, a Clay County procurement conference, and various Naloxone and drug-standards procurements—represent either unrelated service lines or narrow drug-category matches that fall outside emicizumab's clinical scope. The mismatch between the code definition and actual recent activity suggests either inconsistent tagging at the issuing bodies or that state and local governments are not actively procuring emicizumab through posted solicitations at this time.

Recent pharmaceutical and medical-supply activity under or near this code spans county and municipal issuing bodies in Florida, Wisconsin, and Arizona. Dane County's five-year pharmaceutical services contract (term: January 1, 2027 through December 31, 2031, with current annual funding of $125,000) includes daily medication deliveries, dispensing, barcode scanning, and web portal integration, with a local-vendor preference of five points for Dane County-located vendors and two points for adjacent-county vendors. The City of Tucson Fire Department's RFP for BLS and ALS pharmaceuticals and supplies (proposals due June 24, 2026, federally funded through ARPA, HUD, and FTA with Davis-Bacon, DBE, Section 3, and Buy America compliance requirements) encompasses 251 line items with estimated annual usage quantities ranging from 1 to 120,000 units, controlled-substance delivery to stations, and VendNovation vending-machine integration. West Texas Centers for Mental Health and Mental Retardation's RFP for prescription and pharmacy services (proposals due August 21, 2026) covers over 7,000 individuals across 35 sites in 23 counties with 48-hour standard and 24-hour emergency turnaround requirements and Streamline EHR integration. These opportunities confirm active state and local demand for pharmaceutical logistics, inventory management, and dispensing infrastructure rather than specialty-drug procurement narrowly targeting emicizumab.